Abstract
Colorectal cancer is a frequent disease with an increasing incidence. Its prognosis improved recently because of progress in diagnostic and therapeutic procedures. Rationale and guidelines for colorectal cancer screening using the faecal occult blood test in the average risk population and screening recommendations for high risk groups are presented, as well as diagnostic and therapeutic principles. Because of the efficacy of the new chemotherapy regimens, the availability of biotherapies and the fact that surgery can potentially cure more and more patients, colorectal cancer management needs to be multidisciplinary.
Publication types
-
Comparative Study
-
English Abstract
MeSH terms
-
Adenocarcinoma / diagnosis
-
Age Factors
-
Aged
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
-
Clinical Trials as Topic
-
Colonic Neoplasms / diagnosis
-
Colonoscopy
-
Colorectal Neoplasms / diagnosis*
-
Colorectal Neoplasms / drug therapy
-
Colorectal Neoplasms / mortality
-
Colorectal Neoplasms / surgery
-
Colorectal Neoplasms / therapy*
-
Follow-Up Studies
-
Humans
-
Immunotherapy
-
Liver Neoplasms / diagnosis
-
Liver Neoplasms / secondary
-
Liver Neoplasms / surgery
-
Lung Neoplasms / diagnosis
-
Lung Neoplasms / secondary
-
Lung Neoplasms / surgery
-
Lymphatic Metastasis / diagnosis
-
Magnetic Resonance Imaging
-
Mass Screening
-
Middle Aged
-
Neoplasm Metastasis / diagnosis
-
Neoplasm Recurrence, Local / diagnosis
-
Occult Blood
-
Prognosis
-
Risk Factors
-
Time Factors